AgeX Therapeutics Inc (STU:0X40)
€ 13.7163 0 (0%) Market Cap: 25.61 Mil Enterprise Value: 29.32 Mil PE Ratio: 0 PB Ratio: 2.19 GF Score: 36/100

AgeX Therapeutics Inc Discussion of Aging and Regeneration Transcript

Sep 04, 2019 / NTS GMT
Michael West
AgeX Therapeutics, Inc. - CEO & Founder

Hello. My name is Michael West, and I'm the CEO of AgeX Therapeutics. Today we're going to be discussing a paper we recently published in the journal, Regenerative Medicine, on a unified theory of aging and regeneration. In doing so, we'll be making certain forward-looking statements that have associated risks and uncertainties. And so, we refer our viewers to our filings with the Securities and Exchange Commission for more detailed information about the company.

So, there are occasions in the history of science and technology when there's a disruptive event. So, things are going along more or less as normal. And then when this barrier occurs, everything changes. We're seeing that right now in aging research. Historically, aging is be thought of as entropy. It's wear and tear. Our cars wear out. Our houses wear out. Everything else does. So why not humans?

We now recognize in science that aging is reprogrammable. It's [epigenetic] program. It's development. And the fact that it's reprogrammable has profound consequences for all of us

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot